At #CUAnschutz, we push further because what lies beyond the limits of today could change someone’s tomorrow. Our teams are working toward possibilities that once seemed out of reach.

Dreamers never quit. ✨ Discover more at cuanschutz.edu/dreams

A new #CUAnschutz study found that HSV-1 may do more than cause cold sores. The virus can reprogram the brain’s immune cells, potentially linking viral infection to chronic inflammation and increased vulnerability to Alzheimer’s disease. 🧠
🔗: bit.ly/48gUGAL

This week, we’re celebrating the election of four #CUAnschutz doctors to @theNAMedicine! With only up to 100 new members selected each year, this is one of the highest honors in health and medicine.

Learn More: bit.ly/47vJpfN

Why does shingles pain linger long after the virus is gone? #CUAnschutz research suggests that tiny particles in the blood, called exosomes, may continue sending inflammatory signals to nerve cells.
🔗: bit.ly/46WrKNT

A few glimpses of autumn at #CUAnschutz. 🍂

New #CUAnschutz research is offering hope for people living with SPS. Led by Amanda Piquet, MD, a clinical trial found lasting improvements in mobility and overall disability one year after a single treatment with an experimental CAR T-cell therapy.

🔗: bit.ly/4jsVRUJ

For a patient like Ross Matthews, who has undergone six years of treatment for stage 4 colorectal cancer, the need for more options is pressing. Learn how Dr. Lieu and his team at #CUAnschutz are pushing the boundaries of treatment with CAR T-cell therapy: bit.ly/4hQTY35

New research reinforces that supporting maternal mental health during pregnancy is also an investment in child health. 🧠 This is the first randomized controlled trial showing that a prenatal depression intervention can affect infant brain structure. ➡️ bit.ly/4hPgYiO

To celebrate Down Syndrome Awareness Month, we asked our team to describe people with Down syndrome in one word. Tune in to hear their responses! 💙💛

@CUAnschutz @GDSFoundation #DownSyndromeAwarenessMonth

Matt spent years trying to manage pressure #headaches, continuous nasal congestion & crushing #fatigue.

He was eventually diagnosed with a CSF-venous fistula and was referred to Peter Lennarson, MD, for surgery @CUAnschutz #CSFLeak clinic --> tr.ee/4hJxoI
#Spine #SpineSurgery #Colorado

Physicians at #CUAnschutz are the first in the Rocky Mountain region to perform a dual-target focused ultrasound procedure for people with advanced Parkinson’s disease. The procedure was performed by a team led by Daniel Kramer, MD, and Drew Kern, MD, MS: bit.ly/4xFE2oK.

A $50M anonymous gift, one of the largest in campus history, will transform care for patients with cerebrospinal fluid leaks by expanding access to specialized care and advancing research and diagnostics.

Read how this landmark gift will shape CSF care: bit.ly/4yOMLGf

Hard to put into words what this means.

A $50M gift to help us transform care for patients with CSF leaks.

I’m incredibly grateful, humbled by the trust, and feel an enormous responsibility to make sure this changes what is possible for these patients.

A remarkable day. And really, just the beginning.

news.cuanschutz.edu/news-stories/c…

Join us in congratulating Wells Messersmith, MD, who has been named director of the University of Colorado Anschutz Cancer Center (@CUCancerCenter), effective October 1. Read the full announcement here: news.cuanschutz.edu/medicine/messe…

Congratulations to Wells Messersmith, MD, the new director of the CU Anschutz Cancer Center.

See the full statement: bit.ly/4yiL1oE

Can AI recognize when it doesn’t know something?

@CUAnschutz researcher Andrea Sikora, PharmD, is studying how large language models (LLMs) handle uncertainty in high-stakes settings like pharmacy—and where they can fall short.

Learn more ➡️ cudbmi.info/ai-idk-4

University of Colorado Anschutz tropical medicine specialist Andrés Henao told The Conversation how dengue spreads through mosquito bites, and why cases are becoming more common in the U.S.
theconversation.com/dengue-carryin…

Alice Soragni, PhD, works in what she calls the "wild west" of ultra-rare #cancers.
She is leading an effort @CUAnschutz to build a precision medicine platform that uses patient-derived tumor organoids to help identify personalized treatments for rare cancers -- > httancerResearch

#CUAnschutz received FDA clearance to launch a clinical trial of a new CAR T-cell therapy for adults with advanced colorectal cancer and children with solid cancers who have exhausted standard treatment options.

💡 Read about the innovative immunotherapy: bit.ly/4dx32r0

A novel combination therapy with first-in-human roots at @CUAnschutz delivered effective and durable responses in patients with advanced, muscle-invasive bladder cancer, according to a new study in the New England Journal of Medicine (@NEJM): bit.ly/4gy26on